Protective role of thymoquinone against liver damage induced by tamoxifen in female rats

Canadian Journal of Physiology and Pharmacology

Volumn 92, Issue 8, 2014, Pages 640-644

  Suddek, Ghada M ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Anti inflammatory; Antioxidant; Liver damage; Rats; Tamoxifen; Thymoquinone

Indexed keywords

ANTIESTROGEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; BENZOQUINONE DERIVATIVE; PROTECTIVE AGENT; TAMOXIFEN; THYMOQUINONE;

ANIMAL; BLACK CUMIN; DRUG EFFECTS; DRUG-INDUCED LIVER INJURY; FEMALE; LIVER; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; BENZOQUINONES; DRUG-INDUCED LIVER INJURY; ESTROGEN ANTAGONISTS; FEMALE; LIVER; NIGELLA SATIVA; PROTECTIVE AGENTS; RATS, SPRAGUE-DAWLEY; TAMOXIFEN;

EID: 84905020752     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/cjpp-2014-0148     Document Type: Article

References (28)

1. Ahotupa, M., Hirsimaki, P., Parssinen, R., and Mantyla, E. 1994. Alterations of drug metabolizing and antioxidant enzyme activities during tamoxifeninduced hepatocarcinogenesis in rats. Carcinogenesis, 15: 863-868. doi:10. 1093/carcin/15.5.863. PMID:8200088.
2. Albukhari, A.A., Gashlan, H.M., El-Beshbishy, H.A., Nagy, A.A., and Abdel-Naim, A.B. 2009. Caffeic acid phenethyl ester protects against tamoxifen-induced hepatotoxicity in rats. Food Chem. Toxicol. 47: 1689-1695. doi:10.1016/j.fct.2009.04.021. PMID:19394397.
3. Ali, B.H., and Blunden, G. 2003. Pharmacological and toxicological properties of Nigella sativa. Phytother. Res. 17: 299-305. doi:10.1002/ptr.1309. PMID: 12722128.
4. Burits, M., and Bucar, F. 2000. Antioxidant activity of Nigella sativa essential oil. Phytother. Res. 14: 323-328. doi:10.1002/1099 1573(200008)14:5<323::AIDPTR621>3.0.CO;2-Q. PMID:10925395.
5. Caballero, F., Gerez, E., Oliveri, L., Falcolff, N., Battle, A., and Vazquez, E. 2001. On the promoting action of tamoxifen in a model of hepatocarcinogenesis induced by p-dimethylaminobenzene in CF1 mice. Int. J. Biochem. Cell Biol. 33: 681-690. doi:10.1016/S1357-2725(01)00056-5. PMID:11390276.
6. Daba, M.H., and Abdel-Rahman, M.S. 1998. Hepatoprotective activity ofthymoquinone in isolated rat hepatocytes. Toxicol. Lett. 95: 23-29. doi:10.1016/S0378-4274(98)00012-5. PMID:9650643.
7. Daniel, W.W. 1991. Hypothesis testing. In Biostatistics: A foundation for analysis in the health sciences. 5th ed. John Wiley & Sons. New York, N.Y.
8. Dragan, Y.P., Fahey, S., Nuwaysir, E., Sattler, C., Babcock, K., Vaughan, J., et al. 1996. The effect of tamoxifen and two of its non-isomerizable fixed-ring analogs on multistage rat hepatocarcinogenesis. Carcinogenesis, 17: 585-594. doi:10.1093/carcin/17.3.585. PMID:8631149.
9. Dunn, B.K., Wickerham, D.L., and Ford, L.G. 2005. Prevention of hormonerelated cancers: breast cancer. J. Clin. Oncol. 23: 357-367. doi:10.1200/JCO.2005.08.028. PMID:15637398.
10. El-Beshbishy, H.A. 2007. Lipoic acid attenuates DNA fragmentation, oxidative stress and liver injury induced by tamoxifen in rats. Asian J. Tradit. Med. 2: 175-188.
11. El-Beshbishy, H.A., Mohamadin, A.M., Nagy, A.A., and Abdel-Naim, A.B. 2010. Amelioration of tamoxifen-induced liver injury in rats by grape seed extract, black seed extract and curcumin. Indian J. Exp. Biol. 48: 280-288. PMID: 21046982.
12. Elefsiniotis, I.S., Pantazis, K.D., Ilias, A., Pallis, L., Mariolis, A., Glynou, I., et al. 2004. Tamoxifen induced hepatotoxicity in breast cancer patients with preexisting liver steatosis: the role of glucose intolerance. Eur. J. Gastroenterol. Hepatol. 16: 593-598. doi:10.1097/00042737-200406000-00013. PMID:15167162.
13. Ellman, G.L. 1959. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82: 70-77. doi:10.1016/0003-9861(59)90090-6. PMID:13650640.
14. Houghton, P.J., Zarka R., de las Heras, B., and Hoult, J.R. 1995. Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Med. 61: 33-36. doi:10.1055/s-2006-957994. PMID:7700988.
15. Jordan, V.C. 2003. Tamoxifen: A most unlikely pioneering medicine. Natl. Rev. Drug Discov. 2: 205-213. doi:10.1038/nrd1031. PMID:12612646.
16. Kakkar, R., Mantha, S., Radhi, J., Prasad, J., Prasad, K., and Karla, J. 1997. Antioxidant defense system in diabetic kidney: A time course study. Life Sci. 60: 667-679. doi:10.1016/S0024-3205(96)00702-3. PMID:9048969.
17. Labbe, G., Pessayre, D., and Fromenty, B. 2008. Drug-induced liver injury through mitochondrial dysfunction: Mechanisms and detection during preclinical safety studies. Fundam. Clin. Pharmacol. 22: 335-353. doi:10.1111/j.1472-8206.2008.00608.x. PMID:18705745.
18. Lee, C.P., Shih, P.H., Hsu, C.L., and Yen, G.C. 2007. Hepatoprotection of tea seed oil (Camellia oleifera Abel.) against CCl4-induced oxidative damage in rats. Food Chem. Toxicol. 45: 888-895. doi:10.1016/j.fct.2006.11.007. PMID:17188414.
19. Liu, C.L., Huang, J.K., Cheng, S.P., Chang, Y.C., Lee, J.J., and Liu, T.P. 2006. Fatty liver and transaminase changes with adjuvant tamoxifen therapy. Anticancer Drugs, 17: 709-713. doi:10.1097/01.cad.0000215056.47695.92. PMID:16917217.
20. Marklund, S.L. 1985. Superoxide dismutase isoenzymes in tissues and plasma from New Zealand black mice, nude mice and normal BALB/c mice. Mutat. Res. 148: 129-134. doi:10.1016/0027-5107(85)90216-7. PMID:3969077.
21. Nagaie, T., Hashimoto, M., Kai, M., Yamashiata, N., Kondo, J., Tokunaga, M., et al. 2005. Changes in hepatic parenchymal ultrasound images in tamoxifen medication patients. Gan To Kagaku Ryoho, 32: 1925-1928. PMID:16282728.
22. Nili-Ahmadabadi, A., Tavakoli, F., Hasanzadeh, G., Rahimi, H., and Sabzevari, O. 2011. Protective effect of pretreatment with thymoquinone against Aflatoxin B(1) induced liver toxicity in mice. Daru, 19: 282-287. PMID:22615670.
23. Oge, A., Sezer, E.D., Ozgonul, M., Bayraktar, F., and Sozmen, E.Y. 2003. The effects of estrogen and raloxifene treatment on the antioxidant enzymes and nitrite-nitrate levels in brain cortex of ovariectomized rats. Neurosci. Lett. 338: 217-220. doi:10.1016/S0304-3940(02)01416-7. PMID:12581835.
24. Ohkawa, H., Ohishi, N., and Yagi, K. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95: 351-358. doi:10.1016/0003-2697(79)90738-3. PMID:36810.
25. Tarantino, G., Conca, P., Basile, V., Gentile, A., Capone, D., Polichetti, G., et al. 2007. A prospective study of acute drug-induced liver injury in patients suffering from non-alcoholic fatty liver disease. Hepatol. Res. 37: 410-415. doi: 10.1111/j.1872-034X.2007.00072.x. PMID:17539815.
26. Tarantino, G., Colao, A., Capone, D., Conca, P., Tarantino, M., Grimaldi, E., et al. 2011. Circulating levels of cytochrome C, gamma-glutamyl transferase, triglycerides and unconjugated bilirubin in overweight/obese patients with nonalcoholic fatty liver disease. J. Biol. Regul. Homeost. Agents, 25: 47-56. PMID: 21382273.
27. Valizadeh, N., Zakeri, H.R., Amin ansafi, G., Shafiee, A., Sarkhail, P., Heshmat, R., et al. 2010. Impact of black seed (Nigella sativa) extract on bone turnover markers in postmenopausal women with osteoporosis. DARU, 1: 20-25.
28. Williams, G.M., Iatropoulos, M.J., and Karlsson, S. 1997. Initiating activity of the anti-estrogen tamoxifen, but not toremifene in rat liver. Carcinogenesis, 18: 2247-2253. doi:10.1093/carcin/18.11.2247. PMID:9395228.